CHARLES BRAUCHER: Open Payments
NPI 1629007216 · ATHENS, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$893 in 46 payments from 16 companies in 2025. Trend: 2023 $1,156 · 2024 $1,076 · 2025 $893
Food & beverage: $893
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $347 |
| Radius Health, Inc. | 4 | $112 |
| Amgen Inc. | 4 | $69 |
| Lilly USA, LLC | 3 | $59 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| SANOFI PASTEUR INC. | 1 | $26 |
| SANOFI-AVENTIS U.S. LLC | 1 | $25 |
| Verona Pharma, Inc. | 1 | $25 |
| Corium, LLC | 2 | $25 |
Products named: Ozempic, Tymlos, Wegovy, Rybelsus, EVENITY, MOUNJARO, FARXIGA, CAPLYTA.
Industry payments across GA — which companies pay providers there.
